Controversy: Role of cholinesterase inhibitors in dementia care needs rethinking

British Medical Journal

Volumn 333, Issue 7566, 2006, Pages 491-493

  Pelosi, Anthony J ^a   McNulty, Seamus V ^b   Jackson, Graham A ^c  

^a HAIRMYRES HOSPITAL   (United Kingdom)

^b Ayrshire Central Hospital   (United Kingdom)

^c Leverndale Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR;

ALZHEIMER DISEASE; CAREGIVER; CLINICAL TRIAL; DEMENTIA; DRUG BIOAVAILABILITY; DRUG MONITORING; DRUG TOLERANCE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CENTER; HEALTH SERVICE; HUMAN; LONG TERM CARE; MEDICAL SPECIALIST; MEMORY; MENTAL DETERIORATION; NOTE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SOCIOECONOMICS; AMBULATORY CARE; HEALTH CARE QUALITY; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; REVIEW;

AMBULATORY CARE; CHOLINESTERASE INHIBITORS; DEMENTIA; HUMANS; MENTAL HEALTH SERVICES; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE;

EID: 33748440112     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38945.478160.94     Document Type: Note

References (21)

1. National Institute for Clinical Excellence. Technology appraisal guidance number 19, Donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease. London: NICE, 2001.
2. Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, et al. Clinical and cost effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technol Assess 2001;5(1).1-137.
3. Corey-Bloom J, Fleisher AS. The natural history of Alzheimer's disease. In: Burns A, O'Brien J, Ames D, eds. Dementia. 3rd ed. Oxford: Oxford University Press, 2005:376-86.
4. Neumann PJ, Kuntz KM, Leon J, Araki SS, Hermann RC, Hsu MA, et al. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care 1999;37:27-32.
5. Yeo G, Gallagher-Thompson D, eds. Ethnicity and the dementias. Washington, DC: Taylor and Francis, 1996.
6. Yaffe K, Newcomer R, Lindquist K, Covinsky KE. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 2002;287:2090-7.
7. O'Brien JT, Ballard CG. Drugs for Alzheimer's disease. Cholinesterase inhibitors have passed NICE'S hurdle. BMJ 2001;323:123-4.
8. O'Loughlin C, Darley J. Has the referral of older adults with dementia changed since the availability of acetylcholinesterase inhibitors and the NICE guidelines? Psychiatric Bull 2006;30:131-4.
9. Walker Z, Butler R. The memory clinic guide. London: Martin Dunitz, 2001.
10. Hope J. Memory clinics face axe due to drug ban. Daily Mail 2005 Mar 10.
11. Levy R, Post F, eds. The psychiatry of late life. Oxford: Blackwell Scientific, 1982.
12. Dening T. Community psychiatry of old age: a UK perspective. Int J Geriatr Psychiatry 1992;7:757-66.
13. Thompson P, Inglis F, Findlay D, Gilchrist J, McMurdo MET. Memory clinic attenders: a review of 150 consecutive patients. Aging Mental Health 1997;1:181-3.
14. Wilcock GK, Bucks RS, Rockwood K. Diagnosis and management of dementia. Oxford: Oxford University Press, 1999.
15. Boseley S. Lodged in the memory. Guardian 2002 Nov 25.
16. Sheehan B, Saad K. Service innovations: a dedicated drug treatment service for dementia. Psychiatr Bull 2006;30:146-8.
17. Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, et al. The clinical and cost-effectiveness of donepezil, galantamine, and memantine for Alzheimer's disease. Health Technol Assess 2006;10(1):1-176.
18. Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2006;(1):CD001190.
19. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev 2000;(4):CD001191.
20. Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment Cochrane Database Syst Rev 2006;(1):CD001747.
21. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006;(1):CD005593.